Sirtex Cover.proof 11 - School of Educators

More documents

Recommendations

Info

32 Risk Factors The granting of a patent does not guarantee that the patent is valid, the rights of others are not infringed or that competitors will not develop technology to avoid such patents. Sirtex Medical’s success depends, in part, on its ability to obtain patents, maintain trade secret protection and operate without infringing the proprietary rights of third parties. Because the patent positions of medical companies can be highly uncertain and frequently involve complex legal and factual questions, neither the breadth of claims allowed in medical patents nor their enforceability can be predicted. There can be no assurance that any patents which Sirtex Medical may own or control in the future will afford Sirtex Medical commercially significant protection of its technology or its products or have commercial application. As indicated elsewhere, as with most new therapeutic agents, many persons and organisations have been involved in creating and developing the technology being exploited by Sirtex Medical. The Directors cannot exclude the possibility that a person may claim in future an ownership interest in the technology, but the Directors are not aware from their investigations of any such claims having been made against the Company. Risk of Product Liability Sirtex Medical’s business exposes it to potential liability risks that are inherent in the research and development, preclinical study, clinical trials, manufacturing and use of therapeutic products in humans. Sirtex Medical has obtained product liability insurance (see Section 10 for details). However, there can be no assurance that adequate or necessary insurance coverage will be available at an acceptable cost or in sufficient amounts, in the future, or that a product liability or other claim would not materially and adversely affect the business or financial condition of Sirtex Medical.
Section 8 Independent Accountants Report 33
Page 1 and 2: S I R T E X M E D I C A L L I M I T
Page 3 and 4: Chairman’s Letter Chairman’s Le
Page 5 and 6: Section 2 1 The incidence of cancer
Page 7 and 8: Description of the Offer This Prosp
Page 9 and 10: • The extent of public and privat
Page 11 and 12: 4Section Industry Overview Sirtex M
Page 13 and 14: El-Serag and Mason (New England Jou
Page 15 and 16: 5Section Overview of Sirtex Medical
Page 17 and 18: Photograph of radioactive SIR-Spher
Page 19 and 20: Intellectual Property Position The
Page 21 and 22: Temp (c) 46 44 42 40 38 36 34 32 Th
Page 23 and 24: that has not been met with currentl
Page 25 and 26: 5.4.2 Costs of the Business The pro
Page 27 and 28: Manufacture of the SIR-Spheres will
Page 29 and 30: Board of Directors Dr Chris Roberts
Page 31 and 32: Section 7 Risk Factors 29
Page 33: Risk Factors Healthcare Funding Cha
Page 37 and 38: Independent Accountants Report Duri
Page 39 and 40: Independent Accountants Report APPE
Page 41 and 42: Independent Accountants Report (e)
Page 43 and 44: Independent Accountants Report Cons
Page 45 and 46: Independent Accountants Report Cons
Page 47 and 48: Section 9 Reports on Patents 45
Page 49 and 50: Reports on Patents Patent Applicati
Page 51 and 52: Reports on Patents Date: 17 July 20
Page 53 and 54: Reports on Patents Patent Series 2
Page 55 and 56: Reports on Patents Trade Mark Serie
Page 57 and 58: Reports on Patents application unde
Page 59 and 60: Section 10Additional Information 57
Page 61 and 62: Additional Information attaching to
Page 63 and 64: Additional Information Restricted s
Page 65 and 66: Additional Information Material Con
Page 67 and 68: Additional Information • approval
Page 69 and 70: Additional Information Executive Se
Page 71 and 72: Additional Information Consents and
Page 73 and 74: Additional Information of a directo
Page 75 and 76: Glossary of Terms and References Th
Page 77 and 78: Glossary of Terms and References Bu
Page 79 and 80: A B C E F Application Form SIRTEX M
Page 81 and 82: A B C E F Application Form SIRTEX M
Page 83 and 84: Design and Production: Downer Manci

Sirtex Cover.proof 11 - School of Educators

Create successful ePaper yourself

Delete template?

Save as template?